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ARTICLE
Output from VIP cells of the mammalian central
clock regulates daily physiological rhythms
Sarika Paul1, Lydia Hanna 1,2, Court Harding1, Edward A. Hayter1, Lauren Walmsley1, David A. Bechtold 1 &
Timothy M. Brown1✉
The suprachiasmatic nucleus (SCN) circadian clock is critical for optimising daily cycles in
mammalian physiology and behaviour. The roles of the various SCN cell types in commu-
nicating timing information to downstream physiological systems remain incompletely
understood, however. In particular, while vasoactive intestinal polypeptide (VIP) signalling is
essential for SCN function and whole animal circadian rhythmicity, the specific contributions
of VIP cell output to physiological control remains uncertain. Here we reveal a key role for
SCN VIP cells in central clock output. Using multielectrode recording and optogenetic
manipulations, we show that VIP neurons provide coordinated daily waves of GABAergic
input to target cells across the paraventricular hypothalamus and ventral thalamus, supres-
sing their activity during the mid to late day. Using chemogenetic manipulation, we further
demonstrate specific roles for this circuitry in the daily control of heart rate and corticos-
terone secretion, collectively establishing SCN VIP cells as influential regulators of physio-
logical timing.
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The ability to adjust physiology and behaviour in anticipationof daily changes in the environment is critical for survival.Mammals achieve this via a master circadian clock in the
suprachiasmatic nucleus (SCN) whose role is to coordinate rhythms
in cells and tissue function throughout the body according to
predictable individual daily variations in demand1–3.
The SCN comprises a functionally and neuroanatomically
heterogeneous network of neurons, many of which possess
intrinsic timekeeping capabilities, receive input from the retina
and/or other SCN neurons, collectively resulting in robust daily
variations in electrophysiological output4,5. However, despite
remarkable progress in unravelling the basic biological machinery
underpinning SCN timekeeping, the mechanisms by which
rhythmic output from the central clock is used to differentially
time the diverse physiological systems under circadian control
remain a key question.
Subsets of SCN neurons directly innervate various nuclei
important for neuroendocrine, homeostatic and autonomic con-
trol; principally the subparaventricular zone (SPZ), the para-
ventricular nuclei of the hypothalamus (PVN), dorsomedial
hypothalamus, medial pre-optic area and paraventricular
thalamus6,7. SCN cells can also be readily subdivided based on
neuropeptide co-expression, with the best-studied sub-types
(expressing arginine vasopressin—AVP or vasoactive intestinal
polypeptide—VIP) known to provide differential innervation of
these downstream target structures7–10. Accordingly, one pro-
mising hypothesis is that distinct SCN neuronal subpopulations
may provide specifically timed daily output signals to control
rhythms in different aspects of physiology and behaviour11.
While available data support the notion that subsets of SCN
neurons could provide distinctly timed output signals11–14,
attempts to link the function of identified neuron subtypes to
specific aspects of physiological control have primarily focussed
on AVP cells11,15–17. By contrast, while VIP is known to play vital
roles in internal SCN timekeeping18–21, the specific contribution
of VIP cell output to downstream physiological timing remains
largely unexplored. Hence, while various studies have reported
deficits in physiological/behavioural rhythms in mice lacking VIP
or its receptor VPAC222–29, the loss of this signalling pathway
produces a global disruption of SCN rhythmicity18–21. These
generalised impairments, therefore, obscure any specific roles for
VIP cells in physiological control.
Here we employ large-scale multielectrode recording and tar-
geted optogenetic manipulations to define the characteristic daily
activity profiles of individual VIP neurons in the intact adult
mouse SCN and determine how these influence rhythmic activity
in downstream target cells. We then employ chemogenetic
manipulations in freely-behaving mice to reveal specific roles for
the VIP cell output circuitry in shaping rhythms of key clock-
controlled neuroendocrine and physiological outputs.
Results
Properties of SCN VIP neurons. While SCN VIP neurons are
now known to exhibit robust circadian timekeeping proper-
ties30–33, the daily electrophysiological profiles of individual
SCN neurons in the intact adult SCN and their relationship to
whole-animal physiological rhythms remain unknown. To
address this, we employed a mouse line30,34 where VIP cells
express the light-gated cation channel, channelrhodopsin2
(Vip+/cre; Ai32+/−, termed here VIP-ChR2; Fig. 1a) and per-
formed perforated multielectrode array (pMEA) recordings
from the SCN of acutely prepared adult mouse brain slices
(Fig. 1b).
Initially, we evaluated the impact of brief (0.3–3 ms) blue light
flashes via an optical fibre positioned over the SCN during pMEA
recordings across a full circadian cycle ex vivo. Under these
conditions, the number of pMEA recording sites where we
observed excitatory responses increased as a function of flash
duration, with sites located further from the flash centre (and
therefore receiving less light) requiring longer durations to reach
firing threshold (Supplementary Fig. 1a–c). This effect plateaued
for ≥2 ms flashes, where the distribution of electrode sites
showing optogenetic responses matched that expected for SCN
VIP cells30–32,34,35. Accordingly, the observed response latencies
(mean ± SEM: 1.9 ± 0.1 ms; n= 98 responding sites) were similar
those reported previously for direct activation in patch record-
ings34. As a result of this near synchronous activation of VIP
neurons, single unit isolation from these population recordings
was challenging. As such, subsequent experiments employed a
‘ramped’ stimulus (Supplementary Fig. 1d) comprising a train of
multiple brief flashes to de-correlate the activation of individual
VIP neurons. As predicted, these allowed us to readily isolate
optogenetically activated neurons across appropriately located
SCN recording sites (Supplementary Figs. 1d, e and 2a–c). Owing
to the use of these ramped pulses, response latencies were,
however, longer than for simple flashes (mean ± SEM: 6.9 ± 0.7
ms; n= 31 activated neurons from 4 slices).
To confirm that the observed responses reflected a direct
ChR2-mediated excitation, we then applied antagonists of the
main signalling pathways utilised by VIP neurons. Excitatory
optogenetic responses persisted unchanged during application of
a VIP receptor antagonist36 and the GABAA receptor locker
(+)-bicuculline (Supplementary Fig. 1e, g), ruling out possible
synaptic mechanisms. By contrast, among rarer cells displaying
optogenetically-driven inhibition, responses persisted following
application of VIP antagonist but were subsequently abolished
under GABAA-receptor blockade (Supplementary Fig. 1f, h),
confirming a synaptically-mediated origin. Given the lack of VIP
antagonist effect in these experiments, we also validated the
sufficiency of this manipulation for preventing exogenous VIP-
driven responses. As expected37, bath application of 100 nM VIP
evoked excitatory or inhibitory responses in subsets of SCN
neurons which, in both cases, were reliably prevented by
antagonist pre-treatment (Supplementary Fig. 2d–g). As reported
previously then34, the optical stimuli employed here do not drive
any noticeable VIP-receptor mediated responses in VIP-
ChR2 mice.
Having established an approach for reliable identification of
VIP neurons, we employed ramped stimuli during long-term
pMEA recordings from VIP-ChR2 SCN slices (1pulse/min over
≥26 h). From 16 recordings (slices prepared early or late day, n=
8/time-point), 59 neurons were clearly identified as VIP cells
based on optogenetic response (Supplementary Fig. 3a). The
majority of these VIP cells (n= 52/59) displayed robust circadian
variation in spontaneous activity (see methods), with peak firing
strongly clustered across mid-late projected day (Fig. 1c, e, f).
These peak firing times were independent of the time of slice
preparation (median ZT 6.0 vs. 6.6 h for early vs. late day slices, P
= 0.5 from modified-linear multilevel mixed-effects model; n=
35 and 17 respectively), consistent with previous data indicating
that acute electrophysiological recordings of this type reliably
reflect SCN rhythms in the intact animal14,19,38–40.
We also identified many SCN cells that lacked rapid excitatory
responses to optogenetic stimulation (Supplementary Fig. 3b), the
majority which (n= 87/110 non-VIP cells) also exhibited
circadian variations in spontaneous firing (Fig. 1d–f). Indeed,
the basic properties of VIP and non-VIP neurons were very
similar (Fig. 1f–h). Importantly, however, there were differences
in the timing of activity across the two populations. In particular,
while peak VIP cell activity was strongly clustered across the mid-
late projected day, the non-VIP population exhibited a
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significantly broader distribution of peak times that was skewed
towards earlier portions of the day (Fig. 1e). Analysis of within-
slice estimates of clustering and phasing for the two subpopula-
tions produced qualitatively similar results (Supplementary
Fig. 3c–f). Thus, our data indicate that VIP-expressing neurons
constitute a functionally distinct subgroup within the SCN, whose
output primarily occupies a specific temporal window across the
mid-late day.
To confirm that our experimental procedures did not alter the
timing of SCN cell activity, we also compared overall SCN
population output to equivalent data from control mice (VIP+/+;
Ai32+/−; Supplementary Fig. 3a). Importantly, there were no
significant differences in the phase or clustering of SCN cellular
rhythms, the proportion of neurons showing circadian variation
nor the single cell circadian waveforms (Supplementary
Fig. 4a–d). We did, however, find that absolute amplitudes of
VIP-ChR2 SCN firing rate rhythms were modestly reduced
relative to control (Supplementary Fig. 4e), perhaps reflecting the
reduced VIP expression observed in VIP+/cre mice41. Notably,
circadian rhythms in behaviour are not noticeably impaired in
this line, a finding which is consistent with our own observations
that the basic rhythmic properties are intact in VIP-ChR2 slices.
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Fig. 1 Suprachiasmatic nucleus VIP neurons provide a coordinated circadian output. a Antibody enhanced EYFP-signal from the SCN of a VIP-ChR2
mouse. Scale bar: 500 µm. b Light microscope images of a VIP-ChR2 SCN slice in situ on the pMEA; top: overlaid recording site locations, bottom: optical
fibre positioning (460 nm stimulus; 792mW/m2 at fibre tip). c, d Example spontaneous firing activity plots for optogenetically identified VIP (c) and non-
VIP (d) SCN neurons from slices prepared during late (upper panels) or early (lower panels) projected day. e Rayleigh plots showing phase distribution for
isolated VIP (blue) and non-VIP (red) SCN neurons that exhibited circadian variation in firing (n= 52 and 87 cells, respectively, from 16 slices). Individual
cells are represented by open circles, external histograms represent relative population density (Gaussian smoothing; σ= 10 min). Phase and clustering
strength compared by multilevel mixed-effects model (with slice preparation included as a 2nd level random effect) and Browne–Forsythe’s tests,
respectively on linearised data (see Methods). f Proportion of isolated VIP and non-VIP SCN neurons displaying evidence of circadian variation in firing,
compared by Fisher's exact test. g Peak width (full width at half-max firing; left), Peak-trough amplitude for firing rhythm (middle) and 24 h mean firing rate
(right) for rhythmic VIP and non-VIP SCN neurons. Data compared by multilevel mixed-effects linear model as above. h Normalised, peak aligned, 24-h
firing profiles of rhythmic VIP and non-VIP neurons, illustrating the very similar circadian waveforms. *P < 0.05, ***P < 0.001.
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Properties of VIP target neurons. We next sought to identify
downstream neurons that received input from SCN VIP cells.
Accordingly, we evaluated data from long-term (≥26 h) pMEA
recordings spanning known target regions (SPZ, PVN, and ven-
tral thalamus) while optogenetically stimulating the SCN (Fig. 2a,
b; n= 44 VIP-ChR2 slices). Across these targets, we identified a
subset of neurons (herein termed VIPin) that exhibited rapid
attenuation of firing following optogenetic stimulation, consistent
with inhibitory input from SCN VIP neurons (Fig. 2b–d; n=
51 cells). More rarely, neurons exhibiting modest increases in
firing in response to optogenetic stimulation of the SCN were also
identified (Fig. 2b, e; n= 12/718 total cells). Such responses were
qualitatively different from those of SCN VIP cells, exhibiting
sluggish kinetics indicative of a polysynaptic origin (Fig. 2c;
referred to here as slow-activation). Collectively then, these data
indicate that VIP cells convey primarily inhibitory signals to
downstream neurons.
Since SCN VIP cells exhibit maximal firing across the mid-late
subjective day, we next asked whether this translated to an
antiphase rhythm in firing for the VIPin cells that receive this
signal. Accordingly, the majority of VIPin cells (n= 43/51)
displayed clear evidence of circadian variation in spontaneous
firing, with peak firing times distributed across the projected
night and early projected day (Fig. 3b–d; Supplementary Fig. 5a).
The phase clustering in VIPin cells was weaker than that of the
SCN VIP cells themselves (Rayleigh R= 0.21 vs. 0.69, P < 0.0001;
Browne–Forsythe’s test) and was not overtly dependent on the
anatomical location of the recorded neurons (including signifi-
cant clusters in the SPZ region and around the dorsal cap of the
PVN) or the time of slice preparation (Supplementary Fig. 5b–f).
Nevertheless, collectively there was a clear absence of VIPin cells
whose peak firing occurred during the mid-late projected day
(Fig. 3c) and, across the population, average firing rates fell
significantly below the daily mean during this epoch (Fig. 3d).
This decrease in VIPin cell activity, which aligns with the daily
peak in SCN VIP cell population firing, is therefore consistent
with a rhythmic inhibitory drive imposed by the SCN VIP cells.
Interestingly, the majority of non-VIPin cells identified in the
same experiments (n= 568/667) also displayed daily variations in
firing, although in this case we found cells exhibiting peak firing
at all phases across the circadian cycle (Fig. 3b, d, e). Thus, across
this population, phase clustering was significantly weaker than
that observed for VIPin cells (Fig. 3b), with many non-VIP cells
exhibiting peak firing during the mid to late day (Fig. 3d). As
expected from the lack of phase clustering in the aggregated cell
population, within-slice phase estimates for non-VIPin cells were
similarly distributed throughout the circadian cycle (Rayleigh R
= 0.1; n= 44 slices). There were also differences in the circadian
properties of the non-VIPin cells; specifically, peak widths were
narrower and peak to trough amplitudes and mean firing rates
lower than observed for VIPin cells (Fig. 3g, h).
In sum, input from SCN VIP cells is specifically associated with
high amplitude circadian variation in the firing of downstream
target cells, which characteristically exhibit low activity during
mid-late portions of the day and high activity during the night or
early day.
Impact of VIP cell output on target neurons. We next inves-
tigated the mechanisms by which activation of VIP neurons
modulates the firing rate of VIPin cells. For practical reasons, here
we used penetrating multisite probes (rather than pMEA) to
sample neurons across VIP cell target regions in ex vivo VIP-
ChR2 slices while optogenetically stimulating the SCN (Fig. 4a).
Data obtained using this closely approach matched the results of
pMEA recordings, however. Hence, we again identified a subset
of neurons across the VIP cell target regions that exhibited
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reliable decreases in firing following optogenetic stimulation
(Fig. 4a; n= 37 VIPin) and a smaller subset that exhibited slow
activations (n= 3/561 isolated neurons). Stimulus-driven
decreases in VIPin cell firing were prevented by (+)-bicuculline,
with no further change in activity following co-application of the
VIP antagonist (Fig. 4b, c; n= 19 VIPin cells tested). Similarly,
(+)-bicuculline attenuated responses in the 3 cells which exhib-
ited slow-activation (Fig. 4b, c), consistent with the polysynaptic
origin of these responses suggested above.
In sum, our data suggest that SCN VIP cells primarily influence
the firing of their downstream target neurons via GABA rather
than VIP signalling. Given recent data indicating that paired
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high-frequency stimuli are required for VIP-dependent phase
shifts in VIP-ChR2 mice30, we next evaluated the impact of
paired optogenetic stimulation at instantaneous frequencies
spanning the range exhibited by VIP neurons (Supplementary
Fig. 6a; 0.5–40 Hz). Across this range, VIPin cell responses were
reliably predicted by a linear sum of the response to low
frequency (0.5 Hz) single pulse stimulation, as were responses of
those showing slow-activation (Supplementary Fig. 6b, c).
Moreover, in all cases tested, responses were essentially abolished
by (+)-bicuculline treatment as for single pulse stimuli
(Supplementary Fig. 6d, e).
We also examined the impact of sustained SCN VIP cell
stimulation (Fig. 4d; 5s blocks of 0.5–40 Hz stimulation). As
expected, this manipulation evoked a rate-dependent decrease in
the steady-state firing of VIPin cells (Fig. 4e). The maximal
inhibition (57 ± 8% decrease in spontaneous firing) was consis-
tently observed following stimulation at 20 Hz (Fig. 4e, f)—
generally considered as the upper limit for spontaneous SCN cell
firing20. As above, however, responses to sustained optogenetic
stimulation were reliably abolished by (+)-bicuculline across all
frequencies (Fig. 4f).
Our data, therefore, confirm that SCN VIP cells can exert a
powerful influence over the activity of their downstream target
neurons and that this effect is primarily driven by GABA rather
than VIP signalling. Since, in our experiments (+)-bicuculline
preceded VIP antagonist application, we do not exclude the
possibility that VIP release could exert some modulatory
influence over these GABA-dependent changes in VIPin cell
firing. Nonetheless, we also found that bath application of
exogenous VIP exerted negligible effects on the firing rate of
VIPin and neighbouring non-VIPin neurons (Supplementary
Fig. 6f, g). Most likely then, the mouse SCN primarily employs
VIP for internal communication rather than output (at least to
those regions we recorded from), an idea supported by the
paucity of VIP receptors across the recorded regions in mice42,43.
To establish how GABAergic output from VIP cells influences
daily rhythms in their postsynaptic target neurons, we next
assessed the impact of optogenetically inhibiting SCN VIP cell
firing. Accordingly, we established a mouse line in which VIP
cells express the light-gated proton pump Archaerhosopsin-3
(VIP+/cre; Ai40+/−; termed here VIP-Arch) and performed long-
term pMEA recordings from the SCN and target regions (n=
23 slices).
As expected, illumination of VIP-Arch slices with yellow light
(10 s steps) rapidly decreased firing of a subset of SCN neurons,
typically followed by rebound excitation on termination (Fig. 5a;
n= 16/67 SCN neurons). Just as in VIP-ChR2 mice, SCN VIP
cells identified in this manner reliably exhibited peak spontaneous
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mean ± SEM baseline-subtracted firing rates across the population (e; n= 12 cells) during exposure to repeated stimulation (10ms flashes) at varying
frequencies, prior to and following antagonist treatment as above. fMean ± SEM normalised change in firing (relative to no stimulation) for VIPin cells (n=
12) as a function of optogenetic stimulation frequency during pre-drug and antagonist treatment conditions. Data analysed by multilevel mixed-effects
linear model (Frequency: F5,21.785= 6.99, P < 0.001; Treatment: F2,20.357= 49.72, P < 0.001; Interaction: F10,23.401= 16.71, P < 0.001) with Sidak’s post-test.
***P < 0.001, **P < 0.01.
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firing across the mid-late projected day (Fig. 5b). Similarly,
recordings across VIP-cell target regions revealed a subset of
neurons that exhibited rapid increases in firing in response to
illumination of the SCN, as expected for a disinhibition of VIPin
cell activity (Fig. 5d; n= 16/248 cells). These VIPin cells exhibited
the expected circadian variations characterised by peak firing
during the night or early day (Fig. 5e).
We subsequently analysed data from these experiments to
determine the impact of acute Arch-inhibition on the circadian
activity of VIP cells and their downstream targets (see Methods).
This manipulation did not completely silence VIP cells, which
continued to express daily variations in firing during Arch-
inhibition, albeit with substantially diminished amplitude
(Fig. 5c). As a consequence, the portions of the day when VIP
cells were firing at a high rate (>50% of the spontaneous
maximum) was severely truncated under these conditions
(Fig. 5g). In line with these changes, optogenetic inhibition of
SCN VIP cell activity produced a corresponding increase in the
duration of the VIPin cells’ active epoch (Fig. 5g). These data,
therefore, support the view that inhibitory input from SCN VIP
cells substantially influences the circadian firing patterns
VIPin cells.
We further found asymmetrical changes in circadian waveform
of VIPin cell firing. Specifically, analysis of both absolute and
proportional changes in spike output revealed a phase-dependent
modulation of VIPin cell responses, with consistently robust
increases in activity when Arch-stimulation coincided with the
daily rise rather than decline in spontaneous firing (Fig. 6h, i). By
contrast, Arch-mediated inhibition of SCN VIP cells did not
display an equivalent phase-dependency (Fig. 5h, i). This
indicates that the asymmetrical increases in VIPin cell firing
reflect circadian variation in the degree of spontaneous inhibitory
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Fig. 5 Optogenetic inhibition of SCN VIP cells modulates daily variations in VIPin cell activity. a, d Peri-event histograms for example SCN VIP (a) and
extra-SCN VIPin (d) cells identified in pMEA recordings from VIP-Arch slices by 10s yellow light steps applied to the SCN region (565 nm, 140mW/mm2
at fibre tip; means of ~300 trials). b, e Example spontaneous firing activity from optogenetically identified SCN VIP (b) and extra-SCN VIPin cells (e), from
slices prepared during late (top panels) or early (bottom panels) projected day (traces correspond to units in a, d). c, f Mean ± SEM normalised, peak
aligned, 24 h firing profiles of SCN VIP (c) and extra-SCN VIPin neurons (f) under baseline conditions and during Arch activation. g Mean ± SEM durations
of rising and falling phase of the daily peak (time to <half-max) for SCN VIP and extra-SCN VIPin neurons under baseline conditions and during Arch
activation. Data for each class was analysed by multilevel mixed-effects linear model (VIP cells—Arch effect: F1,43.72= 32.94, P > 0.001; Rising vs. falling
phase: F1,4.761 = 0.03, P= 0.86; Interaction: F1,43.72 = 0.47, P= 0.50; VIPin cells—Arch effect: F1,36.58= 5.77, P= 0.02; Rising vs. falling phase: F1,18.72=
0.004, P= 0.95; Interaction: F1,36.58= 0.22, P= 0.64). h, i Mean ± SEM Arch-driven change in firing rate (h) and firing rate modulation (i; (Arch-
spontaneous)/(Arch+spontaneous)) for SCN VIP (blue) and extra-SCN VIPin (purple) neurons across different quartiles of the cells’ daily firing rhythm. In
both cases data for each class analysed by multilevel mixed-effects linear model (h VIP cells: F3,38.66 = 7.26, P= 0.001; VIPin cells: F3,21.88= 5.68, P=
0.005; i VIP cells: F3,15.05= 0.30, P= 0.88; VIPin cells: F3,139.99= 4.67, P= 0.004).Tukey’s post-tests were applied where ANOVA reported a significant
effect; *P < 0.05, ***P < 0.001.
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input from SCN VIP cells and highlights a primary role for SCN
cell group in controlling the daily rise in VIPin cell firing.
Impact of VIP cell output on physiology. Having established
that circadian output from SCN VIP cells shapes rhythmic
activity in downstream recipient neurons, we next investigated
the physiological significance of this clock output pathway. Here,
we employed a chemogenetic strategy to acutely modulate VIP
cell output, by microinjecting viral constructs encoding Cre-
dependent Gq- or Gi-coupled DREADDs or control vector into
the SCN of VIP+/cre mice (Fig. 6a). As expected31,44, this resulted
in strong transfection of neurons within the ventral, VIP-cell rich,
region of the SCN in VIP+/cre mice but no transfection in VIP+/+
animals (Supplementary Fig 7a–c).
We then used this approach to examine the impact of VIP cell
activity on circulating corticosterone, a major clock-controlled
endocrine signal where a potential regulatory influence of SCN
VIP neurons has previously been postulated11. To this end, we
compared circulating corticosterone in virally transfected mice
before and 90min following injection of vehicle or a DREADD-
selective45 dose of clozapine (CLZ; 0.1 mg/kg; see Methods). Based
on our neurophysiological data and the endogenous diurnal
profile of circulating corticosterone in mice (Supplementary
Fig. 8), we performed these studies over three different epochs
(Fig. 6c), where endogenous corticosterone levels were stable and
sub-maximal but spontaneous VIP cell activity was high (mid-
day) or low (early-day and early-night).
Vehicle administration did not significantly alter circulating
corticosterone levels at any time-point for any of the experimental
groups (Supplementary Fig. 8b–d). Similarly, in Gq-DREADD-
expressing mice we did not find any significant effect of activating
SCN VIP cells across any of the test epochs (Fig. 6c), nor did CLZ
injection result in significant changes in circulating CORT in
control vector expressing mice (Fig. 6e). By contrast, chemoge-
netic inhibition of VIP cells in Gi-DREADD-expressing animals
significantly increased circulating corticosterone, with particularly
robust effects at the mid-day epoch (Fig. 6d). Accordingly, the
observed changes in circulating CORT (relative to pre-injection
levels) in these Gi-DREADD-transfected animals were signifi-
cantly larger than those for the vector control group (two-way
mixed effects ANOVA; virus: F1,14= 14.8, P= 0.002; Epoch: F2,28
= 2.05, P= 0.15; Epoch X virus: F2,16= 1.49, P= 0.24; Sidak’s
post-test at mid-day timepoint, P= 0.01). This mid-day time-
point, where greatest effects were observed, corresponds to the
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Fig. 6 Chemogenetic inhibition of SCN VIP cells modulates circulating corticosterone concentrations. a Schematic showing the viral constructs delivered
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schematic indication of epochs used for analysis of response to DREADD-based manipulation: tail bleed samples were taken immediately prior to injection
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normal peak in spontaneous SCN VIP cell activity. These data,
therefore, suggest that the endogenous activity of SCN VIP cells is
especially important for supressing day-time corticosterone
release, ensuring that the daily rise is timed to occur just-prior
to activity onset.
To further validate these findings, we also confirmed that
virally delivered Gi- and Gq-DREADDs effectively modulate the
activity of SCN VIP cells. Gi-DREADD-mediated inhibition of
SCN VIP neurons was previously shown to prevent neuronal
activation following nocturnal light pulses36. Accordingly, we
here found in ex vivo recordings from Gi-DREADD-transfected
VIP-ChR2 mice (where the DREADD-mCherry and ChR2-EYFP
signals strongly co-localise; Supplementary Fig. 7d) that CLZ
application during the projected day significantly inhibited the
spontaneous firing of optogenetically identified SCN VIP cells
(Supplementary Fig. 7e, f). Moreover, that effect was associated
with significant increases in the firing of VIPin cells located
outside the SCN (Supplementary Fig. 7e, f). Similarly, we found
that in vivo activation of chemogenetic constructs in Gq-
DREADD transfected VIP+/cre mice at ZT14.5 was sufficient to
significantly elevate c-Fos expression in the SCN (Supplementary
Fig. 7g, h). These data, therefore, confirm that our DREADD-
based strategy effectively modulates SCN VIP cell output and
highlights an important role for this pathways in regulating
endogenous rhythms of circulating CORT.
We next used the same approaches to investigate the
contribution of SCN VIP cells to regulating other key
physiological outputs under clock control, namely heart rate
and locomotor activity. Thus, a subset of Gq- (n= 5), Gi-
DREADD (n= 5) and control vector (n= 6) transfected VIP+/cre
mice were implanted with radiotelemetry remotes, allowing
untethered, home cage, monitoring of heart rate and activity.
The impact of chemogenetic activation or inhibition of SCN VIP
cells was then investigated at equivalent time-points to those used
for assessment of circulating corticosterone.
Inhibition of SCN VIP cells did not significantly alter heart rate
(Fig. 7b, d) or activity levels (Supplementary Fig. 9b, e) across any
of the analysed time-points. Similarly CLZ injection did not
significantly impact heart rate or activity in control vector-
transfected VIP+/cre mice (Fig. 7c, f; Supplementary Fig. 9c, f). By
contrast, Gq-DREADD-driven activation of SCN VIP cells
significantly reduced heart rate relative to matched vehicle
injections, with most reliable effects observed during the early-
day a time-course consistent with previously reported DREADD
effects46 (Fig. 7a, d). Importantly, this effect on heart rate was not
due to suppression of activity (Supplementary Fig. 7a). Hence,
while analysis of the simultaneously acquired activity data did
reveal a significant effect of CLZ in this group, changes observed
in activity levels specifically during this early-day epoch were
essentially identical for vehicle and CLZ (Supplementary Fig. 9d,
Sidak’s post-test: P= 0.47). We did, however, find a modest
suppression of activity following activation of SCN VIP cells
during the early night (Sidak’s post-test P= 0.04), consistent with
a prior report that optogenetic activation of VIP cells during this
time-point suppresses locomotor activity30. Accordingly, while
our data support this view that VIP cell output can acutely
regulate locomotor activity they also indicate a specific role in
regulating daily rhythms in cardiac output that is independent of
this effect.
Discussion
Traditionally, VIP cells have been considered critical for internal
SCN timekeeping, but less so for the downstream communication
of clock signals18–21,47,48. Here we show that, in fact, individual
VIP cells, in acute adult slice preparations, exhibit robust and
tightly coordinated daily variation in spontaneous firing that
shapes cellular rhythms in electrophysiological activity across
major SCN target nuclei. We further show that acute modulation
of VIP cell activity impacts daily rhythms in heart rate and cir-
culating glucocorticoids in a temporally restricted manner, indi-
cating that endogenous VIP cell output regulates key aspects of
clock-controlled physiology.
In line with our data, recent studies indicate that VIP cells
also sustain population-level circadian rhythms in Per2 & Cry1
transcription, intracellular Ca2+ and possibly membrane vol-
tage31–33. Similarly, cultured neonatal SCN VIP neurons typi-
cally exhibit robust circadian variation in spontaneous firing
rate30, suggesting electrophysiological rhythms are generated by
VIP neurons in a cell-intrinsic manner. Accordingly, we here
find that the circadian activity profiles for individual VIP cells
in adult SCN slice preparations are similar to those of other
SCN neurons. As a population, however, VIP cell output
rhythms are more closely synchronised than for non-VIP cells.
This arrangement supports previous suggestions that the SCN
contains differentially phased subpopulations of cells with
distinct functional roles11,12 and likely contributes to the
increased population level daytime firing rates reported pre-
viously for VIP vs. other SCN neuron types35.
Consistent with the view that this coordinated VIP cell
population activity plays a specific role in conveying temporal
information to cells outside the SCN, we find a subset of neurons
across known anatomical target sites that receive inhibitory input
from VIP cells. The anatomical distribution of these VIPin cells
matches SCN VIP cell projections as reported by ChR2-EYFP
(present study) and immunohistochemically8, with such neurons
clustering at the level of the SPZ and dorsal cap of the PVN. We
further show that VIPin cells exhibit circadian variations in firing
with a nadir coinciding with the endogenous peak in SCN VIP
cell activity and confirm a causative link between these observa-
tions by demonstrating that appropriately timed manipulation of
VIP cell firing (by ChR2 stimulation or Arch-mediated inhibi-
tion) substantially modulates ongoing VIPin cell activity.
Interestingly, we find that the primary mechanism by which
VIP cells influence these target neurons is via GABA rather than
VIP release. This observation is consistent with anatomical data
indicating that VIP receptors are almost entirely absent from the
SPZ, PVN and ventral thalamus in mice42,43. By contrast, VPAC2
receptors have been detected in the rat PVN49, which may explain
previous observations that exogenous VIP50–52 can modulate
corticosterone secretion in that species. While these pharmaco-
logical studies are not necessarily indicative of the physiological
roles of endogenous VIP signalling, it seems possible that the
relative contributions of GABA and VIP signalling to SCN VIP
cell output may differ between species.
Of note, we also find that the timing of peak firing among
VIPin cells is substantially more variable than that of VIP cells
themselves, implying that these daily variations in firing do not
entirely reflect a passive response to circadian rhythms in inhi-
bitory GABAergic input from SCN VIP cells. Rhythmic expres-
sion of core clock genes has been observed in those locations
where we find VIPin cells53–55, thus local clocks might also
(directly or indirectly) contribute to the circadian variation
observed in their activity. Similarly, SCN cells other than those
that express VIP also send projections to SPZ, PVN and ventral
thalamus8–10 and could, in principle, also influence the firing of
VIPin cells in some way. Naturally, in vivo, additional rhythmic
factors not present in our slice preparation could also influence
the temporal profile of VIPin cell activity, although the population
rhythms we observe correspond well with those obtained in
recordings from a key VIP cell target region (SPZ) in freely-
behaving animals56.
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The above not-withstanding, it is abundantly clear that the
circadian timing information provided by SCN VIP cells is not
only a significant influence on the electrophysiological activity of
VIPin cells but, also, shapes daily variations in crucial features of
whole-animal physiology. Accordingly, we find that chemoge-
netic inhibition of SCN VIP cells during their mid-day peak
results in marked increase in circulating corticosterone; a major
systemic regulator of cell physiology and source of circadian
timing information for peripheral tissue clocks57. Specifically, our
data indicate that endogenous circadian variation in VIP cell
output shapes the daily rhythm in glucocorticoid secretion by
suppressing release during the mid-late day, ensuring that the
daily rise in circulating corticosterone is timed to occur just
before the active phase.
Previous attempts to understand the neural circuits underlying
circadian control of corticosterone in rats suggest that AVP
release from the SCN provides a similar inhibitory control during
earlier portions of the day58,59. This is believed to reflect a sti-
mulatory of effect of AVP on inhibitory interneuorns that
innervate corticotrophin-releasing hormone (CRH) cells in the
PVN11. Such a mechanism potentially accounts for our
observation that chemogenetic activation of SCN VIP cells during
the early day (when endogenous activity is low) does not
noticeably suppress levels of circulating corticosterone. Similarly,
the lack of effect following activation of SCN VIP cells during the
early night presumably reflects the fact that the nocturnal decline
in circulating corticosterone is primarily driven by its own
feedback-inhibition of hypothalamic-pituitary-adrenal axis
activity15.
By contrast to the above, our observation that inhibition of
SCN VIP cell activity drives increases in circulating corticosterone
during the mid-late day could most simply be interpreted as
reflecting a direct inhibitory control on CRH neuronal activity.
However, both VIP cell efferents8 and VIPin cells are sparse
within the PVN regions that containing CRH neurons43. A
polysynaptic connection between SCN VIP cells and the PVN
CRH population is certainly possible (involving interneurons in
the SCN and/or other SCN targets) but we do not find evidence
for a major output of this nature in our electrophysiological
studies employing opto- and/or chemogenetic manipulations,
with very few neurons displaying the hallmarks of polysynaptic
activation.
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Fig. 7 Chemogenetic excitation of SCN VIP cells modulates heart rate during the early day. a–c Heart rate following vehicle or clozapine (CLZ; 0.1 mg/kg
i.p.) injections at varying portions of the daily cycle in animals expressing Gq- (a), Gi-DREADD (b) or mCherry (c) in SCN VIP cells. Arrows above traces
indicate timing of injections; grey shaded areas represent time of lights off. d–f Change in heart rate 1–5 h post vehicle or clozapine injection (relative to
mean values in the 2 h epoch preceding injection) for Gq- (d), Gi-DREADD (e) and mCherry (f) expressing mice. Data were analysed by two-way RM-
ANOVA (d: CLZ: F1, 4= 891.3, P < 0.0001; Epoch: F2, 8= 16.57, P= 0.0014; Epoch X CLZ: F2, 8= 1.84, P= 0.22; e: CLZ- F1, 4= 0.52, P= 0.51; Epoch: F2, 8
= 6.76, P= 0.02; Epoch X CLZ: F2, 8= 2.06, P= 0.19; f: CLZ: F1, 5= 0.52, P= 0.50; Epoch: F2, 10= 3.48, P= 0.07; Epoch X CLZ: F2, 10= 1.28, P= 0.32).
Sidak’s post-tests at individual epochs were performed on data form Gq-DREADD expressing animals (c; where ANOVA reported a significant main effect
of CLZ). *P < 0.05.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-15277-x
10 NATURE COMMUNICATIONS |         (2020) 11:1453 | https://doi.org/10.1038/s41467-020-15277-x | www.nature.com/naturecommunications
In sum, we think it more likely that chemogenetic inhibition of
SCN VIP cells impacts circulating corticosterone via a mechanism
independent of the CRH pathway. Accordingly, the dorsal cap of
the PVN (which our data highlight as a key target of SCN VIP cell
output) contains numerous spinally projecting neurons60,61. Since
SCN-dependent changes in the activity of pre-autonomic neurons
in the PVN provides an additional source of control over the daily
rise in circulating corticosterone (by adjusting adrenal cortex
sensitivity to ACTH15,62,63), VIP cell input to such spinally
projecting neurons appears the most likely candidate for the
effects seen here. While future studies will be required to defi-
nitively resolve this issue, the previous observation that SCN VIP
cells innervate PVN neurons that are multisynaptically connected
to the adrenal63 certainly supports the mechanism
suggested above.
We also show that VIP cell stimulation produces a prolonged
decrease in heart rate with especially robust effects during early-
day. These changes in heart rate are not associated with any overt
effects on behavioural activity, although we do find evidence that
activation of SCN VIP cells can supress behavioural activity
during the early-night (as reported previously for optogenetic
stimulation30). These data, therefore, suggest a specific role for
VIP cells in regulating daily variations in cardiac function. Since
chemogenetic inhibition of SCN VIP cells during their mid-day
peak does not produce correspondingly large increases in heart
rate, we infer that the ability of endogenous VIP cell firing to
influence heart rate is restricted under our experimental condi-
tions. This presumably reflects other ongoing rhythmic process
that impact heart rate throughout the diurnal cycle, including
gross changes in activity, arousal state and autonomic tone as well
as potentially circadian clock mechanisms located in the heart
and/or circuity downstream of the SCN53–55,64.
Regarding the circuitry responsible for effects of VIP cell
activity on heart rate, as above, the dorsal cap of the PVN where
we find VIPin cells contains spinally projecting neurons60,61, as
well as cells projecting to the rostral ventrolateral medulla65.
Either/both populations of neurons could contribute to the effects
on heart rate observed here66. Certainly our analyses of electro-
physiological responses imply that direct effects of VIP cell output
on this PVN cell group provide the most likely (and simplest)
potential origin for such effects, as discussed above for corticos-
terone. Future studies would be required to definitively rule out
alternative, less direct, actions however (e.g., multisynaptic
pathways involving the SPZ and DMH).
Regardless of the precise neural circuits involved, our findings
establish VIP-expressing SCN neurons as a major source of cir-
cadian timing information for downstream neural circuits
implicated in neuroendocrine and autonomic control. In line with
other emerging data indicating that the SCN employs specifically
timed neural outputs to control distinct aspects of physiology and
behaviour16,67, these findings provide vital new insight into the
mechanisms by which the central clock aligns whole body func-
tion to the environment.
Methods
Animals. All animals were used in accordance with the Animals, Scientific Pro-
cedures, Act of 1986 (UK) and received both institutional ethics committee and UK
Home Office approval. Experimental animals were generated by crossing VIP-
IRES-Cre mice (JAX #010908)68 and animals bearing Cre-dependent channelr-
hodopsin2 (ChR2)-EYFP (Ai32; JAX #0102569)69 or Archaerhodopsin 3-EYFP
(Ai40D; JAX #021188) constructs, as appropriate. Mice were housed in 12:12-h
light/dark cycles in a temperature controlled environment (22 °C). Zeitgeber time
(ZT) 0 was designated as time of lights-on and ZT12 as lights-off. Food and water
were provided ad libitum.
Ex vivo electrophysiological recordings. Electrophysiological experiments were
performed on male and female mice (age 41–164 days), that were heterozygous for
VIP-IRES-Cre and either Ai32 (VIP+/cre; Ai32+/−, termed VIP-ChR2; experiments
presented in Figs. 1–4 and Supplementary Figs. 1–7) or Ai40 (VIP+/cre; Ai40+/−,
termed VIP-Arch; experiments presented in Fig. 5). Where relevant, control data
was obtained from VIP+/+; Ai32+/− animals (Supplementary Fig 4).
Mice were removed from the home cage at ZT0-1 or ZT11-12 and culled via
cervical dislocation, followed by decapitation and brain removal. Coronal slices
(350 μm thickness) containing the mid-rostrocaudal extent of the SCN (where VIP
cells are concentrated8) and the PVN were prepared using a 7000 smz-2 vibrating
microtome (Campden Instrument, UK). Slicing was performed in an ice cold
sucrose slicing solution (4 °C; sucrose (189 mM); D-glucose (10 mM); NaHCO3
(26 mM); KCl (3 mM); MgSO4 (5 mM); CaCl2 (0.1 mM); NaH2PO4 (1.25 mM)),
oxygenated with 95% O2/5% CO2. Slices were subsequently placed in aCSF solution
(NaCl (124 mM); KCl (3 mM); NaHCO3 (24 mM); NaH2PO4 (1.25 mM); MgSO4
(1 mM); glucose (10 mM); CaCl2 (2 mM), 0.0001% gentamicin (Sigma-Aldrich,
UK)), oxygenated with 95% O2/5% CO2 and left to rest at room temperature for
~20 min. Slices were further equilibrated within the recording setups for 1–2 h
prior to the start of electrophysiological data collection.
For multielectrode array recordings, procedures were similar to those described
by Hanna et al.70. Slices were aligned on 6 × 10 perforated multielectrode arrays
(pMEAs; Multichannel Systems, MCS, Germany; Fig. 1), such that recording sites
spanned either the SCN and SPZ, or the PVN, SPZ and ventral thalamus. Slice
position was visualised under white light trans-illumination using a GXCAM-1.3
camera attached to a dissecting microscope (GX optical, UK) and snapshots were
taken to verify placement over electrode sites. Whilst in the recording chamber
both slice surfaces were constantly perfused with warm oxygenated aCSF (33 °C ±
1 °C) at a rate of ~3 ml a minute. Consistent flow was driven by a constant vacuum
pump (MCS gmbH, Germany) removing waste aCSF, and a peristaltic pump (120S
Watson-Marlow, Falmouth, UK; flow rate ~3 ml/min) delivering fresh oxygenated
aCSF. Slice position was maintained using a weighted harp (ALA Scientific
Instruments, NY, USA), alongside the suction caused by the flow of aCSF through
the perforated MEA array. Neural activity was then acquired continuously over
>26 h using MC_Rack software via a USB-ME64 system and MEA1060UP-BC
amplifier (MCS GmbH, Germany). Signals were sampled at 50 kHz and high pass
filtered at 200 Hz (Second order Butterworth). Spikes crossing a threshold
(normally set at −16.5 µV) were then extracted as timestamped waveforms (1.5 ms
duration) and single unit activity was isolated offline by principle components
based spike sorting using Offline Sorter (V3; Plexon, TX, USA) and NeuroExplorer
(V5; Nex Technologies).
For ex vivo recordings using penetrating multisite electrodes, coronal brain
sections (prepared as described above) were transferred to a heated submerged slice
chamber (BSC-1; Digitimer Ltd., Welwyn Garden City, UK) and held down by a
weighted harp (ALA Scientific Instruments). Bath temperature was maintained at
~33 °C and fresh, pre-warmed and oxygenated aCSF was supplied by peristaltic
pump (120S Watson-Marlow; flow rate ~1.5 ml/min). Silicon 32-channel electrodes
(Buszaki 32L, NeuroNexus, MI, USA), each consisting of 4 shanks with 8 closely
spaced electrodes (see Fig. 4), were then positioned within the brain slice (with the
aid of a dissecting microscope) such that recordings sites either spanned the SPZ,
PVN and ventral thalamus or (for Gi-DREADD validation in Supplementary
Fig 6d–f) the SCN, SPZ and PVN. Neural signals were acquired by a SmartBox
system (Neuronexus) at 20 KHz with spike extraction and single unit isolation
performed on virtual tetrode waveforms as described in Howarth et al.71 using
custom Matlab (Mathworks, MA, USA) scripts and Offline sorter software.
Pharmacological manipulation. At the end of all experiments slices received 5 min
bath applications of N-methyl-D-aspartic acid (NMDA, 20 μM) to confirm viabi-
lity, followed by tetrodotoxin citrate (TTX, 1 μM), to confirm that acquired signals
exclusively reflected Na+-dependent action potentials. Where relevant, slices also
received one or more of the following compounds, singly or in combination: VIP
(100 nM), the VIP receptor antagonist [D-p-Cl-Phe6,Leu17]-VIP (1 µM),
(+)-bicuculline (BIC, 20 µM) to block GABAA receptors and/or D-(-)-2-amino-5-
phosphonopentanoic acid (D-AP5, 50 µM) and 6-cyano-7-nitroquinoxaline-2,3-
dione disodium (CNQX, 20 µM) to block ionotropic glutamate receptors. For Gi-
DREADD validation experiments, slices received clozapine (CLZ, 100 nM). All
compounds were obtained from Sigma-Aldrich (Poole, UK) or Tocris (Abingdon,
UK). Drugs were stored as 1000X stock solutions at −20 °C (In ddH2O or, in the
case of BIC and CLZ, DMSO) and were diluted to working concentrations in pre-
warmed, oxygenated, aCSF just prior to use.
Optogenetic manipulation. For all experiments, an optical fibre (200 µm core;
0.66NA; Plexon) was positioned directly above the SCN (~100–200 µm above slice
surface). For studies employing ChR2, illumination was provided by a PlexBright
tabletop 460 nm module (Plexon), providing ~792 mW/m2 output at the fibre tip.
For long-term pMEA experiments, we applied ‘ramped’ stimuli (consisting of a
sequence of 60–140 µs flashes for a total of 3 ms illumination over a 9 ms epoch) at
a rate of 1/min for the duration of the recording (>26 h). For acute experiments
using penetrating electrodes, square wave 10 ms pulses were applied at varying
interstimulus intervals; either as single pulses (0.5 Hz), pairs with ISIs spanning
0.5–40 Hz (repeating interleaved sequence at 2 s/pair) or stimulus trains with rates
from 0.5–40 Hz (repeating 4 s interleaved blocks separated by 5 s of no stimula-
tion). For long-term pMEA experiments employing Arch, illumination was
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provided by a fibre coupled 560 nm LED module (Thorlabs, Ely, UK), providing
~140 mW/mm2 at the fibre tip. Here light was provided as 10 s steps every 5 min
for the duration of the recording.
Data analysis. Analysis of long-term pMEA recordings was performed using
Matlab routines, as described previously70. Isolated neuron firing rates were con-
sidered to exhibit circadian variation when better fit by a sinusoidal function
(constrained to a periodicity of 20–28 h) than a first order polynomial. For
rhythmic channels, the projected ZT of peak firing was then determined from a 60
s binned time-series (smoothed with a 2 h boxcar filter). Peak width and peak
trough amplitude were determined from this smoothed time-series, with the for-
mer representing the duration over which cell firing was >50% of the peak within a
single 24 h cycle. For comparison of cell phasing between populations, Rayleigh
analysis was used to determine circular median and data were subsequently
adjusted to a relative phase such that, within each dataset, each observation was no
more than 12 h displaced from the population median. This linearisation procedure
allowed for conventional tests to assess differences in variance across the popula-
tion (Browne–Forsythe’s test) and the corresponding mean phase. Since we iden-
tified variable numbers of cells corresponding to the populations of interest from
each slice recording, for the latter (and all other group-wise comparisons between
derived measures of individual cell firing activity) we used a multilevel mixed-
effects linear model that included the slice that each cell was recorded from as a
2nd-level random effect (SPSS, IBM, NY, USA).
Acute changes in neural activity evoked by optogenetic stimuli were classified as
excitatory or inhibitory when the average spike counts across multiple stimulus
repeats (typically substantially >100) respectively exceeded the upper or lower
bounds of the 99% confidence limits for prestimulus spike counts (NeuroExplorer
v4; Nex technologies, CO, USA). Latency was determined from the first post-
stimulus bin to exceed this boundary. Where cells exhibited fast excitatory
responses to ChR2 excitation (peak response detected within 10 ms of the light
stimulus) they were considered VIP-expressing cells. Cells matching these criteria
(exclusively located in the SCN) were easily distinguishable from rarely
encountered cells in SCN target regions showing weaker/more sluggish excitatory
responses (slow-activation). To asses synaptic contributions to optogenetically
driven responses, within each relevant experimental block (25 min epochs prior to
and during drug application) we calculated the mean stimulus-driven changes in
spike firing within an appropriate temporal window (25 ms for single pulse stimuli,
5s for trains, individually tailored for paired stimuli based on the duration over
which significant changes in spike rate were observed). Responses were
subsequently compared using a multilevel mixed-effects linear model that included
the slice that each cell was recorded from as a 2nd-level random effect (as above)
and stimulation frequency and/or drug as repeated fixed factors as required.
Planned post-hoc comparisons were then applied as appropriate where significant
main effects of the fixed factors were detected.
For comparison of observed vs. predicted responses to paired optogenetic
stimulation (Supplementary Fig. 6c), we first calculated post-stimulus spike count
histograms for each cell from 0 ms to 500 ms following low frequency stimulation
(LFS, 0.5 Hz) of SCN VIP cells. Predicted response profiles for paired stimulation
were then calculated as a simple linear sum of the initial response histogram
(extracted above) and an appropriately time-shifted version of the same (with the
caveat that the resulting spike counts firing rates were constrained to have a
minimal possible value of zero). We then calculated the mean change in firing rate
for each cell between response onset and offset (first and last bins were firing rates
were significantly below baseline) for both predicted and measured response to LFS
and stimulus pairs and normalised the resulting data series to have maximal value
of one. Group data processed in this way were then analysed by multilevel mixed-
effects linear modelling as above.
For analysis of data from VIP-Arch slices (Fig. 5), cell classification and analysis
procedures were essentially identical to those use for VIP-ChR2 with minor
modifications. Specifically, to compare circadian profiles in the presence/absence of
Arch mediated-inhibition of SCN VIP cells, we first took the raw spike counts over
time, extracted from these epochs with and without illumination, and then used
spline based interpolation to produce the corresponding time-series of mean firing
rate (spikes/s) with 60s resolution, before subsequent processing as above. In
addition, we specifically compared firing rates in the presence and absence of Arch
mediated-inhibition across specific portions of the circadian profile for each cell
(trough, peak, rising and falling; defined respectively by the lower and upper
quartiles of the cells firing profile and the corresponding intervening regions). For
these comparisons, we assessed both absolute and relative changes in firing rate. In
the case of the latter we calculated a standard modulation index of the form (Arch
−spontaneous)/(Arch+spontaneous), The resulting measure was therefore
bounded between −1 and 1 (for Arch-mediated decreases and increases in firing
rate respectively).
Estimates of the anatomical localisation of recorded neurons were obtained
from snapshot images of the slice/recording electrode placements, with recording
electrodes (and units detected therein) being assigned as located within or outside
the SCN based on the observable anatomical boundaries of the nucleus for each
slice, evident in the white light trans-illuminated images. Prior analysis70 indicates
that the actual positions of recorded neurons are likely to lie within ±17 µm of the
recording site centres. Coupled with the fact that the precise anatomical boundaries
between the extra-SCN regions studied here were not always as unambiguously
identifiable in the slice images as for the SCN (in particular the PVN/SPZ border),
we did not categorise these extra-SCN neurons to specific target structures. Instead,
we estimated anatomical positions based the known electrode array geometries
relative to fixed landmarks within the slice; specifically the distance between each
recording site and the intersection of best fit lines through the 3rd ventricle and the
ventral border of the SCN/optic tract. We then present these data as either binned
proportions of identified cells across the dorsal-ventral axis of the slice (Figs. 2b
and 4a) or as estimated positions (Supplementary Fig 5b) mapped onto a
standardised anatomical template derived from the Mouse Brain Atlas72.
Viral injections. Viral injections were performed on male and female mice
(49–157 days old). Experiments were primarily performed in VIP+/cre individuals
(Figs. 6 and 7 and Supplementary Figs. 8 and 9). For additional validation of viral
specificity (Supplementary Fig. 7b, c), injections were performed in VIP+/+ ani-
mals. For electrophysiological validation of the Gi-DREADD approach (Supple-
mentary Fig. 7d–f) mice were heterozygous for both VIP-IRES-Cre and Ai32 (i.e.
VIP+/cre; Ai32+/−).
Mice were anaesthetised using 1% isoflurane in O2, and placed into a
stereotaxic frame following which the skull was exposed. Craniotomy and bilateral
injection of virus was completed using a motorised injector under computer
control (Drill and 473 Microinjection Robot: Neurostar, Tϋbingen, Germany).
Subsequently, 69 nl of viral vector encoding an activating or inhibiting DREADD
or control construct (AAV2-hSyn-DIO-hM3D(Gq)-mCherry, AAV2-hSyn-DIO-
hM4D(Gi)-mCherry or AAV2-hSyn-DIO-mCherry respectively; Addgene, MA,
USA) was delivered at 25 nl/s. Micropipettes were left in place for 5 min following
injection, and were then retracted in 100 µm/5s increments until above the SCN.
Corticosterone measurements. Tail vein blood samples (5 µl) were collected,
following needle puncture, into heparinised capillary tubes (Drummond Micro-
caps, 5 μl). Samples were dispensed into 20 µl of PBS and placed on ice before
centrifuging (VWR Micro Star 17r; 10,000× for 10 min 4 °C), with the resulting
supernatant stored at −80° until analysis.
To assess diurnal variation in cortisol level, samples were collected at 9 time-
points across the day-night cycle. Collections completed during the dark phase of
the animals were performed under dim red light and animals were allowed
sufficient time to recover between sample collections to allow tail healing and
stress-induced corticosterone dissipation (minimum 3 days between sampling).
Tail blood sampling for DREADD expressing animals was performed at defined
epochs across the diurnal cycle (early day, mid-day and early night). Blood was
initially sampled at ZT1, 6 or 14.5, immediately followed by injection of a
DREADD-selective45 dose of clozapine (0.1 mg/kg i.p.; Tocris) or vehicle (0.01%
DMSO in saline). This dose of clozapine has previously been shown to produce
comparable effects to those commonly used for the original DREADD activator
(10 mg/kg), which does not cross the blood brain barrier and therefore requires
metabolic conversion to clozapine in order to act centrally45. Moreover, at 0.1 mg/
kg, the clozapine dose used here is ~10-fold lower than the threshold for non-
DREADD mediated effects in other systems45,73.
Ninety min post injection a second blood sample was collected (a timeframe
chosen to encompass the expected peak in DREADD effects). Testing at each epoch
was separated by at least 5-days to avoid any lingering effect of the prior
manipulations.
In all cases, serum samples were subsequently analysed using pre-coated ELISA
plates (ABCAM, ab108821; Cambridge, UK). Concentration changes were assessed
using two-way RM ANOVA with Sidak’s multiple comparisons (GraphPad Prism,
CA, USA).
Radiotelemetry. Mice were anaesthetised using 1% isoflurane in O2. Once deeply
anaesthetised, an incision was made into the peritoneal cavity and ETA-F10 radio
telemetry devices (Data Sciences International; MN, USA) inserted. The muscle
lining was sutured and the electrodes of the ECG telemetry remote were routed
subcutaneously and sutured to lie on either side of the heart. Once electrodes were
in position the wound was closed. Animals were administered analgesia (Bupre-
norphine 0.01 mg/kg) and left to recover for one week before the start of experi-
ments. During the experiment, mice were singly housed (with ad libitum food)
under a 12:12 h light-dark cycle. ECG/activity signals were acquired by a receiver
pads placed under the mouse’s home cage (RPC-1; Data sciences international).
Activity counts and heart rate (bpm) were acquired in 5 min intervals for the
duration of the experiment. For assessment of DREADD-based manipulation of
SCN VIP cell activity commenced, animals received vehicle injection (0.01%
DMSO in saline, i.p.) at one of three time-points (ZT 1, 6 or 14.5) and subsequently
a DREADD-selective clozapine injection (0.1 mg/kg, i.p) at an equivalent timepoint
the following day. Initial testing was preceded by a 3-day baseline recording epoch
and at least five days drug free days were left between testing at each timepoint.
For visualisation of responses to chemogenetic manipulations, data (5 min bins)
were smoothed with a Gaussian function (σ= 30 min). For subsequent analysis, we
extracted the change in HR or activity 1–5 h post i.p. injection, relative to the mean
value in the preceding 2 h epoch for each animal. This time range was chose to
avoid acute changes in heart rate/activity induced by the injection and to
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encompass that over which DREADD-based responses were reported
previously45,46. The resulting data were then analysed by two-way RM ANOVA
with Sidak’s multiple comparisons (GraphPad Prism).
Immunohistochemistry. At the end of experimental procedures, virally injected
mice were deeply anaesthetised with urethane (10%; i.p. injection) and transcar-
dially perfused with 4% paraformaldehyde. Brains were removed and post-fixed
overnight in 4% paraformaldehyde, before being dehydrated in 30% sucrose.
Sections were then cut at 50 μm on a freezing sledge microtome (8000 Sledge;
Bright Instruments, UK) and blocked for 3 hs (10% Donkey serum, Sigma Aldrich;
0.2%PBS-T) at room temperature. To confirm viral expression, the intrinsic
mCherry tag was amplified by incubation with primary antibody (rabbit anti-ds
red; 1:2500; TaKaRa Bio, CA, USA; 2.5% donkey serum, 0.2% PBS-T) overnight at
4 °C. Following a 30 min wash (0.2%PBS-T), sections were incubated with sec-
ondary antibody (Alexa 546 donkey anti rabbit; 1:1000; Thermo Fisher Scientific;
2.5% donkey serum, 0.2%PBS-T) for 4 h at room temperature. Sections were then
mounted using vectashield hardset with DAPI (Vector Labs, H-1500).
A subset of Gq transfected animals underwent concurrent staining for c-Fos
activation. Clozapine (0.1 mg/kg, i.p) was delivered 90 min prior to transcardial
perfusion, which occurred at ZT16. Protocol was as above, with additional primary
antibody (chicken anti c-Fos; 1:200; Sigma Aldrich), and additional secondary
antibody (Alexa 488 donkey anti chicken; 1:500; Thermo Fisher Scientific).
For visualisation of VIP cell terminal fields, VIP+/cre; Ai32+/− mice were
transcardially perfused, sectioned and processed as above, substituting the primary
(chicken anti-GFP; 1:10,000; Abcam, Cambridge, MA, USA), and secondary
antibodies (Alexa 488 donkey anti chicken; 1:500; Thermo Fisher Scientific) to
allow visualisation of the intrinsic EYFP tag expressed by VIP cells in these
animals. For DREADD virus expression (Supplementary Fig. 7d–f) these antibodies
were used concurrently with those above for mCherry visualisation.
Images were collected on a Zeiss Axioimager.D2 upright microscope using a
10×/0.5 EC Plan-neofluor objective and captured using a Coolsnap HQ2 camera
(Photometrics; AZ, USA) through Micromanager software v1.4.23. Images were
then processed and analysed using Fiji ImageJ.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Materials, algorithms and data generated in these studies are available from the authors
upon reasonable request.
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